[HTML][HTML] Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain

AS AlZaman, SA Mughal, YS AlZaman… - Saudi medical …, 2016 - ncbi.nlm.nih.gov
Objectives: To assess the correlation between hormone receptor status (HRS) and age, and
its significance as a predictor of outcome in patients with breast cancer (BC). Methods: This …

Breast cancer in patients with sickle cell disease can be treated safely with weekly paclitaxel.

AS Al Zaman - Saudi Medical Journal, 2013 - europepmc.org
Breast cancer is the most common malignancy among females; nevertheless, so far no data
is available in the literature on the safety of oncological treatments in patients with sickle cell …

Breast Cancer in SCD Patient: A Case Report and Literature Review

E Al-Zaman, AS Al-Zaman… - Asian Journal of Medical …, 2023 - globalpresshub.com
Background: Malignancies have been often reported among patients with sickle cell disease
(SCD), with breast cancer being the most common cancer among females. However, the …

[PDF][PDF] The Correlation of Age with Various Prognostic Factors in Breast Cancer in Iraqi Patients

AR Hassoon, HS Ali, HM Said - Iraqi Medical Journal, 2021 - imj.edu.iq
Aysha S AlZaman et al (on 109 patients with breast cancer between 2010 through 2013
in … (58.9%) which is comparable to a similar study by Aysha S AlZaman et al (about 57%)(10) …

Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population …

J Fraser, N Steele, A Al Zaman, A Yule - European Journal of Cancer, 2011 - Elsevier
PURPOSE: In our institution, adjuvant taxanes are currently offered to fit, node positive
breast cancer patients who are either Her2 positive (any ER/PR) or triple negative (ER/PR/Her2 …

[PDF][PDF] The safety and tolerability of FE

ASAL Zaman, YSAL Zaman… - Clinical Cancer …, 2013 - ccij-online.org
Introduction: In our institution, adjuvant taxanes are currently offered to fit node-positive
breast cancer patients who are either Her2 positive (any ER/PR) or triple negative (ER/PR/Her2 …

Women and the Media in Oman

R Al Talei - Arab Women and the Media in Changing Landscapes, 2017 - Springer
… Soon after getting married to Aysha he too became a strict religious Muslim. For most … ’s
sports projects. I was also writing a weekly article in the newly established newspaper Alzaman

Mending the Egyptian Gap

EED Aysha - Arab and Muslim Science Fiction: Critical Essays, 2022 - books.google.com
… Qahir Al Zaman was published the following year, and so began the career of Nihad Sharif—a
history graduate originally—one of the most distinguished Egyptian SF writers to this day. …

A histopathological study on breast carcinoma with special reference to cyclin-D1 and estrogen receptor

P Hazari, MK Deka, B Kanoo - Journal of Current …, 2024 - submission.journalofcoms.com
Introduction: Breast cancer is the most frequent cause of cancer-related death in women in
developing nations. Breast cancer diagnoses have increased as a result of rising awareness …

The safety and tolerability of FE [sub] 100 CD chemotherapy in a non-trial population of node positive breast cancer compared to PACS-01 trial group; Salmaniya …

AAL Zaman, YAL Zaman, EAL Zaman - Clinical Cancer Investigation …, 2013 - go.gale.com
Materials and Methods All patients commencing adjuvant FE [sub] 100 CD chemotherapy at
a regional cancer centre (Salmaniya Medical Complex) between 1 [sup] st January 2007 …